NCAPG and hepatocellular carcinoma: To experimentally validate the CRISPR screen data, we transiently knocked down NCAPG expression by transfecting 2 sequence-independent siRNAs targeting NCAPG separately into HCCLM3 and HepG2 HCC cell lines (Fig. 3A).